PRIMECAP Management started to build up the position in Johnson & Johnson in Q1 2013 and continued to invest until Q2 2013. Since then they sold 14 Million shares. The investor completely sold their stake between Q3 2013 and Q3 2019.
Josh speaks to experts about the state of markets amid President Trump's tariff pause and trade tensions escalating with China. Other topics include bank ear...
Capstan Therapeutics, a San Diego, CA-based biotechnology company dedicated to advancing in vivo reprogramming of cells through RNA delivery using targeted l...
Guinness Asset Management LTD boosted its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 2.8% in the third quarter, according to the company in it...
Signet Financial Management LLC lessened its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 3.5% in the third quarter, HoldingsChannel reports. The f...